melanomanon-small cell lung canceranti-PD-1 therapy
…thods We conducted a retrospective analysis of samples from 111 melanoma patients treated with anti-PD-1 therapy to quantify PD-1/PD-L1 …
126articles mentioning diseases
162disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: Non-small cell lung cancer ×
Non-small cell lung cancer
This disease is selected. Its supporting articles are shown below.
Articles mentioning Non-small cell lung cancer
126 articles · page 8 of 11NSCLCnon-small cell lung cancerRilvegostomig
…tomig, an anti-PD-1/ TIGIT bispecific, for CPI-naïve metastatic NSCLC with PD-L1 1-49% or ≥50%. J Thorac Oncol. 2024;19:10,S33.…
non-small cell lung cancerNSCLCRilvegostomigHBS regulatory board
…g has demonstrated encouraging results in a Phase I/II trial of non-small cell lung cancer (NSCLC) ( NCT04995523), and is currently being evaluated in mul…
NSCLCnon-small-cell lung cancernon-small cell lung canceripilimumabnivolumabplatinum doublet chemotherapyMD Anderson Cancer Centerplatinum doublet therapyplatinum-doublet chemotherapy
…+N therapy.Methods Immunotherapy-naïve patients with metastatic NSCLC were treated with ipilimumab and nivolumab per the LONESTAR tri…
92.5%
melanomaNSCLChead and neck squamous cell carcinomatriple-negative breast cancernon-small cell lung cancerHNSCCTNBCYale UniversityYale Human Investigation CommitteeICIs
…c data from seven cohorts spanning four cancer types (n = 314): melanoma; n=100, NSCLC; n=117, TNBC; n=42, and HNSCC; n=55. Each cancer …
non-small cell lung cancertislelizumabsintilimabInnoPCVAffiliated Hospital of Guizhou Medical UniversityECOG Performance StatusINV002Anti-PD-1 monoclonal antibody
…oclonal antibody. Individuals with locally advanced or advanced non-small cell lung cancer were enrolled with treatment intended for patients who have ach…
melanomacervical cancerNSCLCpancreatic cancerCRCcolorectal carcinomanon-small cell lung cancerHNSCChead and neck squamous cell carcinomaKSQ-004EX
…EX in patients with select advanced solid tumors. Patients with melanoma, NSCLC, HNSCC, CRC, pancreatic, and cervical cancer who have pr…
non-small cell lung cancersolid tumorssmall cell lung cancerbreast cancerleptomeningeal metastasespemetrexedGuangzhou Medical UniversityIntrathecal PD-1 inhibitorAffiliated Huizhou Hospitalinvolved-field radiotherapy+1 more
…ed.Results From 6/2024 to 3/2025, 31 patients were enrolled (26 non-small cell lung cancer, 4 breast cancer, and 1 small cell lung cancer). At the initial…
mesotheliomacolorectal cancercolorectal cancersnon-small cell lungnon-small cell lung cancersolid tumorsplatinum resistant ovarian cancerCT-95NCT06756035MSLN
…ion by immunohistochemistry (10% ≥ 1+); ovarian, pancreatic and mesothelioma cancer patients will not require prospective screening due to t…
colorectal cancersubmandibular gland cancerovarian cancercholangiocarcinomanon-small cell lung canceradvanced solid tumorsES009Bellberry Human Research Ethics Committee
…dy.Results Twelve patients with advanced solid tumors—including colorectal cancer, cholangiocarcinoma, non-small cell lung cancer, ovarian cancer…
NSCLCnon-small cell lung cancerNational Center for Cancer Care and ResearchHamad Medical Corporation
…tember 2021-June 2023. Sera from 31 locally advanced/metastatic NSCLC patients, eligible for anti-PD-1/PD-L1 or combined chemoimmunot…
non-small cell lung cancerNSCLCMD Anderson Cancer CenterKAN-001CRCHUManti-PD-1 therapyCanadian CouncilPD-1 therapy
…onses to immune checkpoint inhibitors (ICIs) in cancers such as non-small cell lung cancer (NSCLC). Fecal microbiota transplantation (FMT) from ICI-respon…